The Curious Case of FGFR1

October 18, 2021November 3, 2021 - by Steve Ethier

It is well accepted that one of the most important breakthroughs is breast cancer research in terms of its impact on the treatment of patients

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

About Steve Ethier

Professor, Department of Pathology and Laboratory Medicine, MUSC. I am the developer of the SUM breast cancer cell lines, and the SUM Line Knowledge Basse

View all posts by Steve Ethier →

Related Posts

Why it is important for investigators to obtain cell lines from the originating source

CRISPR versus RNAi based screens: Which are more useful when using the data mining tools?

Cell Lines are People Too!

About Steve Ethier